Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
LanzaTech Inc. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct art units and 2 distinct examiners, showing a broad distribution relative to the small number of active cases. This spread across 2 distinct art units indicates that the company's biotechnology innovations are being evaluated under different technical criteria within the USPTO.
MONSHIPOURI, MARYAM is the busiest examiner, responsible for 1 pending office action. The 2 pending office actions are divided equally between the 2 examiners assigned to the portfolio. For the practitioner, this means that each matter requires an independent strategy, as there is no overlap in examiners or art units. The involvement of MONSHIPOURI, MARYAM in only 1 pending office action highlights the individualized nature of the current prosecution for LanzaTech Inc.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MONSHIPOURI, MARYAM | 1 | 79.2% | +37.2% |
| SLAUGOVSKY, RACHEL MARIE | 1 | 70.7% | +39.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18803349 | SYSTEM AND METHOD FOR GENERATING BUBBLES IN A VESSEL | MONSHIPOURI, MARYAM | — |
| 18544828 | INTEGRATION OF ADSORPTION DEVICE AND GAS FERMENTATION | SLAUGOVSKY, RACHEL MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18803349 | SYSTEM AND METHOD FOR GENERATING BUBBLES IN A VESSEL | MONSHIPOURI, MARYAM | — |
| 18544828 | INTEGRATION OF ADSORPTION DEVICE AND GAS FERMENTATION | SLAUGOVSKY, RACHEL MARIE | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| 1776 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18803349 | SYSTEM AND METHOD FOR GENERATING BUBBLES IN A VESSEL | MONSHIPOURI, MARYAM | 1651 | §102§103§112 | Non-Final OA | — | Pending | Aug 13, 2024 |
| 18544828 | INTEGRATION OF ADSORPTION DEVICE AND GAS FERMENTATION | SLAUGOVSKY, RACHEL MARIE | 1776 | §103§112 | Non-Final OA | — | Pending | Dec 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLanzaTech Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Maryam Monshipouri has the most, with 1 of LanzaTech Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
